Lemaitre Vascular EV/EBIT LMAT

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Oct 23, 2026: 22.6×
10-year median: 29.6×
Against its 10-year history: 19th; percentile: 0 is its lowest day, 100 its highest
10-year range: 0.7× to 47.9×
Peer median: 26.2×

Lemaitre Vascular's EV/EBIT is 22.6× as of Oct 23, 2026.

That is below its ten-year median of 29.6×, lower than on 81% of days in the last ten years.

Over that time it ranged from 0.7× in Mar 2020 to 47.9× in Jun 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 26.2×.

EV/EBIT over time

median 29.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	22.6×	20.9×	35.9×
2025	28.1×	27.8×	39.0×
2024	35.1×	30.1×	41.1×
2023	34.9×	27.1×	47.9×
2022	27.4×	21.6×	30.5×
2021	27.8×	25.8×	41.0×
2020	29.7×	0.7×	29.7×
2019	1.4×	1.2×	28.7×
2018	15.1×	14.2×	34.7×
2017	30.6×	24.1×	37.3×
2016	28.1×	18.1×	28.1×
2015	25.7×	17.5×	25.7×
2014	22.9×	21.0×	37.5×
2013	26.0×	16.0×	28.0×
2012	15.9×	9.8×	18.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest Lemaitre Vascular's size, closest first, today.

Company	EV/EBIT
LMATLemaitre Vascular	22.6×
INSPInspire Medical Systems	32.6×
UFPTUFP Technologies	24.9×
EYENational Vision	19.2×
CDRECadre	23.2×
BVSBioventus	26.2×
ATRCAtriCure	208×
WRBYWarby Parker	n/m
STAAStaar Surgical	57.7×
IRMDIradimed	37.7×
NVSTEnvista	14.9×
Peer median	26.2×

Where Lemaitre Vascular ranks

#26of 46Medical instruments and supplies stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Lemaitre Vascular

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.